Product Details:
| strength | 7 mg |
| Form | Tablets |
| Packaging Type | Strip |
| Composition | Semaglutide |
| Brand | Rybelsus Semaglutide 7mg Tablets |
| Manufacturer | Novo Nordisk |
| Shelf Life | 24 Months |
| Usuage | to treat type 2 diabetes |
| Prescription / Non Prescription | Non Prescription |
Rybelsus (Semaglutide 7mg Tablets):
Product Description:
Rybelsus (Semaglutide 7mg Tablets) is an oral medication used to manage type 2 diabetes. It belongs to the GLP-1 receptor agonist class, helping regulate blood sugar levels by stimulating insulin production in response to meals, reducing glucagon secretion, and slowing gastric emptying. Rybelsus is the first oral form of this class, offering a convenient alternative to injectables. This medication is typically prescribed along with diet and exercise to improve glycemic control and may also help with weight management in some patients.
Product Details:
| strength | 3 mg |
| Form | Tablets |
| Packaging Type | Strip |
| Composition | Semaglutide |
| Brand | Semaglutide |
| Manufacturer | Novo Nordisk |
| Shelf Life | 24 Months |
| Prescription/Non prescription | Non prescription |
| Usuage | to treat type 2 diabetes |
Rybelsus (Semaglutide 3mg Tablets):
Product Description:
Rybelsus (Semaglutide 3mg Tablets) is an oral medication used to manage type 2 diabetes. It belongs to the GLP-1 receptor agonist class, helping regulate blood sugar levels by stimulating insulin production in response to meals, reducing glucagon secretion, and slowing gastric emptying. Rybelsus is the first oral form of this class, offering a convenient alternative to injectables. This medication is typically prescribed along with diet and exercise to improve glycemic control and may also help with weight management in some patients
Product Details:
| Strength | 5 mg |
| Packaging Size | 0.5 ml |
| Packaging Type | Injection |
| Brand | MounjaroEli Lilly and Company |
| Treatment | Type 2 Diabetes Mellitus (as an adjunct to diet and exercise to improve glycemic control) Being stu |
Product Details:
| Strength | 100 U/ml |
| Packaging Type | Box |
| Brand | Levemir |
| Manufacturer | Novo Nordisk |
| Composition | insulin detemir |
| Treatment | Indicated for the treatment of diabetes mellitus in adults and children to improve glycemic control |
Product Details:
| Dose/Strength | 500 mg |
| Form | Injection |
| Packaging Size | 500/5ml |
| Packaging Type | vial |
| Composition | tranexamic acid injection IP |
| Strength | 500 mg |
| Manufacture By | Aneta pharmaceutical |
| Brand | Aneta Pharmaceuticals Pvt ltd. |
| Manufactured By | Aneta pharmaceutical |
| Usage / Application | Hospital |
| Usage/Application | Hospital |
| Prescription/Non prescription | Prescription |
| Shelf life | 24 months |
| Storage Conditions | STORE IN COOL, DRY,, DARK PLACE BELOW 25 DEGREE |
| Usage | to control blood sugar levels |
| Manufacturer | Aneta Pharmaceuticals Pvt ltd. |
| Also gives | Pharmaceutical Third Party Manufacturing |
NETACLOT 500 MG/5 ML is typically a medication used to enhance the clotting process in patients with bleeding disorders or to assist in surgical settings. Its active ingredient is usually a form of clotting factor or agent that helps promote hemostasis.
Key Features:Always consult a healthcare professional for detailed information tailored to specific medical needs.
Additional Information: